Nat Rev Drug Discovery 20:309325 Narita Y, Arakawa Y, Yamasaki F, Nishikawa R, Aoki T, Kanamori M, Nagane M, Kumabe T, Hirose Y et al (2019) A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma
Patients with liver disease, abnormal liver function, known glutathione allergy, or those who are pregnant or breastfeeding should not receive IV glutathione
Respiratory arrest, heart failure, and choking on vomit are all fatal risks
Psychiatry Res 284:112691 Haroon E, Woolwine B, Chen X, Pace T, Parekh S, Spivey J et al (2014) IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy